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potent antigen receptor cross-linking, for example bySan Francisco, California 94143±0414
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gens, can induce cells to enter the cell cycle, whereasBeckman Center
less multivalent antigens, including most T-dependentStanford University School of Medicine
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the cell cycle. Cells engaging these antigens are highly
receptive to T cell±derived signals, and the T cell and
antigen receptor signals synergize to promote B cell
Cell fate within multicellular organisms is often deter- proliferation or differentiation into antibody-secreting
mined by the concerted action of several extracellular cells or germinal center cells. As well as regulating cell
signals. In lymphocytes, a signaling complex that con- cycle entry and responsiveness to T cell help, antigen
receptor triggering in mature B cells also affects celltributes to many cell fate decisions is the antigen recep-
migration within lymphoid tissues, causing rapid exit oftor, with different extents of antigen receptor engage-
B cells from follicles or marginal zones and promotingment leading to such outcomes as cell death, survival,
their accumulation in outer T cell zones and other sitesor proliferation.Great strideshave beenmade in the past
(Liu etal., 1991; Cyster et al., 1994; Cyster and Goodnow,two decades in understanding how antigen receptor
1995b; Shokat and Goodnow, 1995; Bachmann et al.,signals are transmitted within cells. It is only in the past
1996; Fulcher et al., 1996). Signaling from the antigenfew years, however, that an understanding has begun
receptor is likely to be controlled at multiple levels, someto develop of what regulates the strength and quality of
molecules acting at the antigen receptor complex itself,the signal. Most excitingly, this regulation involves the
regulating signaling via multiple pathways, and othersaction of multiple transmembrane molecules, leading to
acting further downstream within specific signalingthe recognition that the strength and quality of signal
pathways. It is becoming increasingly apparent that sev-transmitted by the antigen receptor in response to an
eral of the proximal regulators of signal strength andantigen may be regulated both by properties of the anti-
quality are transmembrane molecules such as CD22.gen and the microenvironmental context of the cell.
In this review we discuss the most recent studies on
CD22: A Negative Regulator of Antigena transmembrane regulatory molecule on B cells, CD22,
Receptor Signalingand attempt to put these studies into the context of
The B lineage molecule, CD22, is a member of the immu-other transmembrane molecules that regulate antigen
noglobulin superfamily (Stamenkovic and Seed, 1990;
receptor signal strength in B cells. Finally we speculate
Wilson et al., 1991; Torres et al., 1992) and was sug-
on how these molecules may function to relate microen-
gested to participate in antigen receptor signaling fol-
vironmental information to intracellular signaling from lowing the observation that treatment of cells with anti-
the antigen receptor and cell fate. CD22 antibodies synergized with antigen receptor
cross-linking in promoting B cell proliferation (Pezzutto
et al., 1987; Pezzutto et al., 1988; Tuscano et al., 1996a).B Cell Antigen Receptor Signaling Thresholds
The notion that CD22 contributed positively to antigenThe core units of the B cell antigen receptor are trans-
receptor signaling gained further support with the dis-membrane immunoglobulin (Ig) and the associated mol-
coveries that a fraction of CD22 within B cells can beecules CD79a and CD79b (Iga and Igb) (Reth, 1992).
coprecipitated with the antigen receptor (Leprince et
Antigen receptor cross-linking leads to activation of Src-
al., 1993; Peaker and Neuberger, 1993) and that CD22
family kinases, including Lyn, Fyn and Blk, and phos-
becomes rapidly tyrosine phosphorylated following anti-
phorylation of tyrosines within ITAM motifs in the CD79 gen receptor engagement (Schulte et al., 1992; Leprince
cytoplasmic domains. Protein tyrosine kinase Syk asso- et al., 1993; Peaker and Neuberger, 1993; Williams et
ciates with the phoshorylated CD79 ITAMs and is acti- al., 1994). More recently it has been observed that CD22
vated by phosphorylation. The concerted action of Syk, can associate with the tyrosine kinases Lyn and Syk
Src-family kinases, and otherdownstream kinases leads and with PI3-kinase and phospholipase C-g (PLCg) (Law
to the rapid phosphorylation of multiple substrates and et al., 1996; Tuscano et al., 1996b).
to the activation of calcium pathways, the Ras/Erk path- The positive regulatory activity of CD22 was brought
way, additional mitogen-activated protein±family ki- into question, however, when it was observed that the
nases, and possibly other signaling pathways (Gold and SHP-1 protein tyrosine phosphatase (PTPase; pre-
DeFranco, 1994). Antigen receptor signaling in B cells viously PTP1C), which negatively regulates antigen re-
has different consequences depending on the stage of ceptor signaling (Cyster and Goodnow, 1995a), rapidly
B cell maturation and the strength and duration of the associates with CD22 following antigen receptor en-
signal. In immature B cells, extensive antigen receptor gagement (Campbell and Klinman, 1995; Doody et al.,
cross-linking reversibly arrests development and pro- 1995; Law et al., 1996). Characterization of the SHP-
motes clonal elimination or receptor editing, whereas 1±binding sites in CD22 identified three of the six cyto-
plasmic tyrosines, each in the motif V/IXYXXL, that whenengagement of less potently cross-linking antigens does
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Figure 1. Role of CD22 and SHP-1 in Negatively Regulating Signaling in Resting and Activated B Cells
Spontaneous firing and antigen-induced firing of the antigen receptor (sIg) may normally be counteracted by CD22/SHP-1 such that in cells
lacking either of these molecules, basal as well as antigen-induced signaling is elevated.
phosphorylated were able to bind and activate SHP-1 for SHP-1 and negatively regulate antigen receptor sig-
naling (Figures 1 and 2). Candidate targets for SHP-(Doody et al., 1995). This tyrosine-based motif was pre-
1±mediated dephosphorylation are CD79a and b, Lyn,viously observed as a SHP-1±binding site in Fc receptor
Syk, CD19, and PLCg, and a goal of future work will be(FcR) FcgRIIb (D'Ambrosio et al., 1995) and has now
to identify the specific targets of this phosphatase withinbeen identified in the killer-inhibitory receptors on natu-
the cell after it is recruited to CD22.ral killer (NK) cells that also recruit SHP-1 (Burshtyn et
Down-modulation of sIgM on B lymphocytes occursal., 1996).
rapidly following antigen engagement, the extent ofThe potential role of CD22 as a negative regulatory
modulation increasing with the dose and valency of anti-molecule was supported by an experiment in which it
gen (Goodnow et al., 1989). The exaggerated down-was cross-linked independently of surface immuno-
modulation of sIgM reported in mature CD22-deficientglobulin (sIg) using anti-CD22 coated beads: an en-
and SHP-1±deficient B cells compared to wild-typehanced anti-immunoglobulin response was observed,
cells, in the absence of increased antigen engagement,and it was suggested that drawing CD22 away from an
suggests that basal or constitutive signaling may beinteraction with sIg limited the extent to which it could
elevated in theabsence of CD22/SHP-1±mediated nega-negatively regulate antigen receptor signaling (Doody
tive regulation (Cyster and Goodnow, 1995a; O'Keefe etet al., 1995). This experiment could not fully exclude
al., 1996; Otipoby et al., 1996; Sato et al., 1996; Nitschkethe possibility that CD22 was transmitting a positive
et al., 1997). Recruitment of SHP-1 to CD22 may not
signal that synergized with sIg signaling, and this is
be restricted to the period following antigen receptor
where gene knockout experiments have filled an impor-
engagement by antigen but may occur at a low level
tant gap. B cells from mice made deficient in CD22 by continuously, counteracting the ªspontaneous firingº of
targeted gene disruption, established independently by the receptor (Figure 1). Following antigen receptor en-
four groups (O'Keefe et al., 1996; Otipoby et al., 1996; gagement, CD22 phosphorylation is increased, and a
Sato et al., 1996; Nitschke et al., 1997), show two charac- much larger battery of SHP-1 molecules is recruited and
teristic and striking properties: exaggerated elevation activated (Figure 1).
in intracellular calcium in response to antigen receptor SHP-1 is recruited to the cell membrane by multiple
cross-linking, and spontaneous modulation of sIgM on receptor systems and in each case it appears to play a
peripheral B cells. The similarity of this phenotype with negative role (Scharenberg and Kinet, 1996). Within B
that previously observed for B cells deficient in SHP-1 lymphocytes, SHP-1 is recruited to the cytoplasmic do-
(Cyster and Goodnow, 1995a) supports the view that a main of FcgRII following co±cross-linking of sIg and
FcgRII (D'Ambrosio et al., 1995), and SHP-1 recruitmentmajor function of CD22 in B cells is to serve as a dock
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Figure 2. Model of Relationship among CD45,
Lyn, CD22, and SHP-1 in B Cell Antigen Re-
ceptor Signaling
CD45-mediated dephosphorylation of Lyn
(or related Src-family kinase) activates the
kinase domain (red), which then phosphory-
lates (yellow dots) multiple substrates, in-
cluding CD22 (green). Iga and Igb alsobecome
tyrosine phosphorylated. Syk associates with
phosphorylated Iga/b, and SHP-1 with phos-
phorylated CD22. Additional associations of
these molecules may also occur. The strength
and quality of signals transmitted depend on
the balance between recruitment of Syk (and
other kinases) and SHP-1. The transition to
an active complex is promoted by antigen
receptor cross-linking but may also occur
spontaneously. CD22/SHP-1 promotes inacti-
vation of the signaling complex.
may account for the down-regulation of signaling that reduced proliferative responses depending on the rela-
tive amount of cell death, which might be influenced byoccurs upon immunoglobulin±FcR co±cross-linking.
However, recent studies suggest that SHP-1 cannot ac- such features as the type of anti-immunoglobulin cross-
linking agent used and the duration of the in vitro assay.count for all of the negative regulatory activity of FcgRII
and that the lipid phosphatase, SHIP, that is also re- The delicate balance between proliferation and death
may also account for the reduced in vivo antibodycruited to the receptor participates in the negative func-
tion (Ono et al., 1996). Because SHIP is recruited to response to type II T-independent antigens but the
normal or slightly elevated response to T-dependentthe same tyrosine-phosphorylated motif in FcgRIIb as
SHP-1, it is possible that SHIP may also be recruited antigens in CD22-deficient animals. Type II T-indepen-
dent antigens, such as the trinitrophenol-Ficoll used inby other molecules that have been found to bind SHP-1,
such as CD22. This possibility warrants further investi- studying the CD22-deficient mice (Otipoby et al., 1996;
Sato et al., 1996; Nitschke et al., 1997), are multivalentgation since it bears on the issue of whether transmem-
brane regulatory molecules control the quality as well polymers and are thought to induce B cell responses
by extensively cross-linking the antigen receptor. Theas strength of antigen receptor signaling (Scharenberg
and Kinet, 1996). However, the similar albeit less severe reduced response in some of the studies (Otipoby et
al., 1996; Nitschke et al., 1997) might therefore reflectphenotype of B cells deficient in CD22 compared to
SHP-1 deficiency argues that CD22 negatively regulates exaggerated signaling in TNP-specific B cells causing
their elimination. T-dependent antigens, by contrast,antigen receptor signaling largely by recruiting SHP-1.
The identification of a negative function for CD22 does generally have a lower valency and might be less likely
to induce apoptosis of CD22-deficient B cells. Further-not exclude the possibility that it may also have a posi-
tive signaling role. Two tyrosine-containing motifs in the more, presentation of the antigen to T cells should per-
mit rescue signals to be transmitted by various costimu-CD22 cytoplasmic domain are similar to the ITAM motifs
of CD3 and CD79 molecules (Leprince et al., 1993; latory molecules, such as CD40, whose function remains
intact in CD22-deficient B cells (O'Keefe et al., 1996;Peaker and Neuberger, 1993), and one or other of these
motifs may participate in recruiting Lyn, Syk, PI3-kinase, Otipoby et al., 1996; Sato et al., 1996; Nitschke et al.,
1997). It is striking nevertheless that isotype switching,and PLCg1 (Law et al., 1996; Tuscano et al., 1996b).
Complexes of CD22 containing Syk, PLCg1, and SHP-1 germinal center formation, and somatic mutation con-
tinue to occur in the absence of CD22, because thesehave been reported(Law et al., 1996).The reduced prolif-
erative response of CD22-deficient B cells following an- processes are severely disrupted in animals deficient
in two other B cell transmembrane regulatory molecules,tigen receptor cross-linking may reflect a lack of positive
regulation by CD22 (Otipoby et al., 1996; Sato et al., CD19 and CD21 (Engel et al., 1995; Rickert et al., 1995;
Ahearn et al., 1996; Molina et al., 1996). These observa-1996). However, reduced proliferation was not a consis-
tent observation in CD22-deficient cells, with one study tions suggest that CD22 does not play an essential role
in B cell±T cell interactions, despite the ability of thedemonstrating increased proliferation (O'Keefe et al.,
1996), and an alternate explanation may be that CD22- extracellular domain to mediate interactions between
these cell types (Aruffo et al., 1992).deficient B cells transmit exaggerated signals for cell
death as well as cell cycle entry, a possibility directly
demonstrated in one study (Nitschke et al., 1997). The CD22, CD5, and SHP-1 Regulate
Peritoneal B-1 Cellsmore rapid turnover of peripheral B cells in CD22-defi-
cient mice (Otipoby et al., 1996; Nitschke et al., 1997) Mice deficient in SHP-1 have an enlarged pool of B-1
cells, with most B cells in spleen and lymph nodes bear-and the failure to accumulate normal numbers of mature
B cells in SHP-1±deficient mice (Cyster and Goodnow, ing the B-1 phenotype (Sidman et al., 1986). Many stud-
ies indicate that the antibodies expressed by B-1 cells1995a) are also consistent with elevated signals leading
to increased cell death. Therefore the outcome of prolif- are polyreactive and bind weakly to multiple endoge-
nous antigens (Kantor and Herzenberg, 1993), raisingeration assays may easily be shifted from elevated to
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the possibility that the type of antigen receptor signals indicating that tolerance mechanisms are probably not
disrupted in the animals. A more detailed investigationa B cell receives during development regulates entry
into theB-1 compartment. In immunoglobulin transgenic of B cell tolerance, perhaps using an immunoglobulin-
transgenic model, is needed to establish whether CD22mice it has been found that when immunoglobulin
transgenes are derived from conventional (B-2) B cells, participates in setting thresholds of antigen receptor
engagement for B cell elimination.the transgenic mice make B-2 cells but few B-1 cells
(Kantor and Herzenberg, 1993). However, when SHP-1±
deficient mice are crossed to immunoglobulin-trans- Lyn-Deficient and CD22-Deficient B Cells
genic mice of the B-2 receptor type there is a marked Have a Similar Phenotype
accumulation of peritoneal B-1 cells bearing this recep- Interestingly, increased numbers of B-1 cells, elevated
tor specificity (Cyster and Goodnow,1995a), furthersug- serum IgM and IgA, and reduced B cell lifespan are also
gesting that SHP-1 normally functions to inhibit B cell properties observed in Lyn-deficient mice (Hibbs et al.,
accumulation in this compartment. B-1 cells express 1995; Nishizumi et al., 1995). Although the primary stud-
CD22 (Andersson et al., 1996; Erickson et al., 1996), ies of Lyn-deficient animals showed reduced anti-immu-
and it was therefore important to ask whether B-1 cells noglobulin induced proliferative responses, these ani-
accumulated to a higher frequency in CD22-deficient mals may have been deficient in conventional B cells
mice. A small increase in the size of this compartment by the time of analysis because recent experiments with
was seen in two of the gene knockout studies (O'Keefe cells from young mice show exaggerated proliferative
et al., 1996; Sato et al., 1996). responses (Wang et al., 1996). These studies together
The increase compared to SHP-1±deficient non- highlight similarities between Lyn-deficient, SHP-1±
transgenic mice (Sidman et al., 1986) might be limited deficient, and CD22-deficient B cells and raise the pos-
because some B-1 cells harbor an additional SHP-1 siblity that a major function of Lyn could be phosphoryla-
docking molecule, CD5 (Bikah et al., 1996). CD5 is a tion of transmembrane regulatory molecules to permit
member of the scavenger receptor family, and its cyto- recruitment of SHP-1. Strongly supporting this possibil-
plasmic domain contains an ITAM-like motif that can ity, FcgRII-mediated inhibition of sIg signaling is defec-
interact with several SH2 containing proteins, including tive in Lyn-deficient cells (Wang et al., 1996). In Figure
SHP-1. In T lymphocytes, CD5 associates with the anti- 2 a model is presented in which Lyn-mediated phos-
gen receptor and, as observed in studies with CD22, phorylation of CD22 leads to SHP-1 recruitment from
cross-linking CD5 can transmit signals that augment the cytosol, activation, and dephosphorylation of Syk
T cell receptor (TCR) signaling. The principal T cell phe- and other positive regulatory molecules. An important
notype in CD5 deficient mice, however, is an exagger- task of future studies will be to determine whether Lyn
ated signaling response consistent with a negative regu- is required for SHP-1 recruitment to CD22. Equally im-
latory role for CD5 (Tarakhovsky et al., 1995). Although portant will be to test whether signaling pathways in
most B lymphocytes are CD5-negative, a fraction of addition to calcium elevation are affected by CD22 (and
peritoneal B-1 cells express CD5 (also called Ly1). B-1 SHP-1) deficiency in B cells and thereby to learn whether
cells normally make an abortive attempt at proliferation CD22/SHP-1 regulates the quality as well as the quantity
and undergo apoptosis following antigen receptor of the antigen receptor signaling response.
cross-linking, and this has beenassociated with a dimin- The more severe B cell phenotype in SHP-1 deficient
ished calcium response and failure to translocate NF-kB mice compared with that associated with CD22 or Lyn
to the nucleus (Morris and Rothstein, 1993). In CD5- deficiency raises the possibility that SHP-1 may also
deficient B-1 cells, by contrast, antigen receptor cross- regulate B cells by CD22- and Lyn-independent path-
linking induces a more sustained calcium response, nu- ways. The B cell phenotype associated with SHP-1 defi-
clear translocation of NF-kB, and a strong proliferative ciency results in part from trans-acting effects through
response (Bikah et al., 1996). Cross-linking CD5 inde- macrophage dysregulation, but when these are con-
pendently of sIg on wild-type B-1 cells, as in the studies trolled for the failure of mature B cells to accumulate
with CD22, also provoked a strong proliferative re- still appears to be more severe (Cyster and Goodnow,
sponse. These studies are consistent with a negative 1995a). This difference might be accounted for by SHP-1
regulatory activity for CD5 in B-1 cells. Although no recruitment to other cell surface receptors in CD22-defi-
increase in B-1 cell frequency is detected in CD52/2 cient cells, such as FcgRIIb (D'Ambrosio et al., 1995)
mice, it is possible that CD22 sufficiently compensates and sIg itself (Pani et al., 1995).
to prevent their accumulation.
B-1 cells are thought to be the major source of natural
CD45: A Positive Regulator of Antigenantibodies in the serum of unimmunized mice (Kantor
Receptor Signalingand Herzenberg, 1993), and in animals with excess B-1
Acting upstream of Lyn, and presumably of CD22 andcells, elevated serum antibody levels are usually ob-
SHP-1, is another transmembrane regulatory molecule,served (Sidman et al., 1986; Kantor and Herzenberg,
CD45. CD45 is a PTPase that positively regulates anti-1993). It seems likely therefore that the increased serum
gen receptor signaling at least in part by dephosphory-IgM and IgA levels reported in 4±6-month-old CD22-
lating the negative regulatory carboxy-terminal tyrosinedeficient mice are a result of the increased numbers of
residues on Src-family tyrosine kinases, activating theB-1 cells (O'Keefe et al., 1996; Sato et al., 1996). A small
kinases (Chan et al., 1994; Trowbridge and Thomas,elevation in the titer of autoantibodies seen in some
1994). In vivo studies in CD45-deficient mice (KishiharaCD22-deficient mice does not appear greater than the
increase in total antibody titer (O'Keefe et al., 1996), et al., 1993) have confirmed the positive role of CD45
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in antigen receptor signaling: B lymphocytes lacking between mature B cells and other cells or molecules in
peripheral microenvironments.CD45 show reduced activation of calcium and Erk sig-
naling pathways and have an elevated threshold for
elimination by self-antigen (Cyster et al., 1996). A striking Role of the Ectodomains in Regulating
Cytoplasmic Domain Functionfinding in CD45-deficient animals carrying immunoglob-
ulin transgenes specific for the soluble antigen hen egg A question that must be raised in considering the func-
tion of CD22, CD45, and other transmembrane mole-lysozyme was that accumulation of mature B lympho-
cytes is impaired but is rescued when the cells devel- cules that regulate antigen receptor signaling in lympho-
cytes is: What is the function of their ectodomains? Ifoped in the presence of the soluble hen egg lysozyme
autoantigen (Cyster et al., 1996). Just as too much sig- all that these molecules needed to do was to provide
cytoplasmic docking or catalytic sites, one might havenaling from the antigen receptor shortens cell lifespan,
as may occur in SHP-1± or CD22-deficient B cells, insuf- predicted that their ectodomains would be similar to
the CD3 or CD79 chainsÐthat is, molecules with smallficient signaling also appears to allow B cell death. The
need for an intact antigen receptor signaling complex extracellular domains (ornone atall) that associate firmly
with the antigen receptor complex. Instead, CD22,for the transition from immature to mature B cell, or
persistence of mature B cells, received further support CD45, and several other regulatory molecules have large
extracellular domains, some of which can exist in multi-from an experiment demonstrating that B cells with a
mutation in the CD79a cytoplasmic domain fail to accu- ple alternatively spliced forms and have well-defined
ligand-binding domains (Trowbridge and Thomas, 1994;mulate in the periphery (Torres et al., 1996).
In addition to the positive signaling pathways that we Tedder et al., 1997). Current insight into how these do-
mains may regulate intracellular domain function hasvisualize CD45 to activate, by dephosphorylating and
activating Lyn, CD45 likely promotes phosphorylation come from studies with antibodies and chimeric mole-
cules. As we have already discussed, cross-linkingof CD22, recruitment of SHP-1, and down-regulation of
the tyrosine kinase±mediated signaling response in a CD22 or CD5 independently of the antigen receptor
complex can enhance signaling from the receptor, sug-negative feedback loop. In this sense CD45 is also play-
inga negative role. An important parameter in controlling gesting that one function of the ectodomains may nor-
mally be to regulate the extent of association with thethe relative intensity of positive and negative pathways
activated by the antigen receptor is likely to be the rela- antigen receptor. Elegent studies with chimeric mole-
cules containing the CD45 cytoplasmic domain linkedtive amount and distribution of CD45 and CD22 (or CD5)
at the cell surface. to the epidermal growth factor receptor extracellular
domain demonstrated that dimerizing this molecule in-
activated the positive signaling role of the CD45 cyto-
Immature B Cells Express Surface CD22 plasmic domain (Desai et al., 1993). Ligand binding to
Many studies have suggested that CD22 is not ex- the intact CD45 molecule might therefore be important
pressed on the surface of immature B cells (Campana in controlling the strength of signaling from the antigen
et al., 1985; Dorken et al., 1986; Loken et al., 1987; receptor. In speculating on the physiologically relevent
Andersson et al., 1996; Erickson et al., 1996). Because ectodomain interactions that might regulate intracellular
SHP-1 negatively regulates signaling in immature bone domain function, three types must be considered: (1)
marrow B cells (Cyster and Goodnow, 1995a), the iden- interactions between molecules on the same cell; (2)
tity of the membrane docking molecule for SHP-1 in interactions between molecules on different cells; and
immature B cells has been unclear. By using the CD22 (3) interactions with soluble antigen complexes and
knockout as a staining control, it has now been shown other molecules.
compellingly that CD22 is expressed on the surface of (1) Tuning the Antigen Receptor by Interactions
both pre-B and immature B cells (Nitschke et al., 1997). between Ectodomains on the Surface
CD22 may therefore act as an important membrane of the Same Cell
docking molecule for SHP-1 in immature as well as ma- The proximity of CD22, CD45, and other regulatory mole-
ture B cells. In the transition from immature to mature B cules with the antigen receptor is likely to be critical in
cells there is an approximately 5-fold increase in surface regulating antigen receptor signaling. The use of extra-
CD22 expression. Whether this increase equates to an cellular domains to mediate such associations might
increased extent of negative regulation of antigen recep- provide a means of regulating the extent of the associa-
tor signaling in mature B cells compared to immature B tion, depending on cellular context. CD22 contains a
cells (O'Keefe etal., 1996) remains to beestablished. The sialic acid a2±6Gal binding lectin in its two amino-termi-
concomitant increase in surface expression of positive nal domains (Stamenkovic et al., 1991; Sgroi et al., 1993;
regulatory molecules CD45, CD19, and CD21 (Tedder Engel et al., 1995; Law et al., 1995; van der Merwe et
et al., 1997) suggests that this interpretation may be too al., 1996), and it may be capable of binding to IgM mole-
simplistic. Furthermore, to the extent that it has been cules on the cell through a2,6-sialylated sugars expressed
tested, immature B cells do not show greater activation on IgM (Hanasaki et al., 1995). Competition for binding
of intracellular signaling pathways in response to anti- to other a2,6-sialylated proteins could then alter this
gens than mature B cells (Yellen et al., 1991; Cyster association (e.g., when the cell is in a particular microen-
and Goodnow, 1995a). An alternative explanation for the vironment) and in turn affect antigen receptor signaling.
increased expression of these regulatory molecules on As B cells become activated, they increase expression
the cell surface as B cells mature is that their extracellu- of b-galactoside a2,6-sialyltransferase (a2,6-ST) (Er-
ikstein et al., 1992). Sialylation of CD22 itself can blocklar domains serve important functions in the interactions
Immunity
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Figure 3. Possible Roles for the CD22 Ecto-
domain
(A) CD22 recognizes the sialylated carbohy-
drate side chainsof membrane IgM on resting
B cells and negatively regulates antigen re-
ceptor signaling. Late after activation, the B
cell increases a2,6-ST expression, and this
may cause theCD22 lectin domain to become
blocked by its own sialic acid groups, reduc-
ing its binding to IgM and permitting en-
hanced BCR signaling.
(B) In a nonlymphoid microenvironment, the
level of a2,6-sialylated carbohydrate may be
low, favoring CD22±IgM association and neg-
ative regulation. When the B cell enters a
lymphoid microenvironment that is rich in
a2,6-linked sialic acid, CD22 may be drawn
away from IgM, augmenting signaling.
(C) BCR binding of an antigen±serum IgM
complex or serum IgM itself (in the case of
an autoreactive B cell) may recruit CD22 into
an association with membrane IgM and in-
hibit signaling. Complement C3d fixation on
the IgM complex might be expected to over-
ride such inhibition by recruiting CD21/CD19.
the ligand-binding domain (Braesch-Andersen and Sta- expression of a2,6-ST by B cells along with the high
expression of heavily glycosylated CD45 makes this in-menkovic, 1994), and this alteration could be a means
by which the cell regulates the extent of sIg±CD22 asso- teraction very probable. The physical dimensions of
CD45 and CD22 are likely to be similar, which mightciation (Figure 3A).
Different splice variants of CD22 that lack either im- further favor an interaction. The functional signifance of
such an interaction is unexplored.munoglobulin domains 3 or 3 and 4 have been described
(Stamenkovic and Seed, 1990; Wilson et al., 1991; Engel (2) Tuning the Antigen Receptor by Ectodomain-
Mediated Interactions between Moleculeset al., 1995), raising the possiblity that alternate splicing
of the extracellular domain might also be used by the on Adjacent Cells
The best-characterized antigen receptor regulatorycell as a means of altering association with sIg. Such a
mechanism has previously been suggested to regulate molecules in this class are CD4 and CD8 on T cells.
Their recruitment into the TCR±major histocompatibilityinteractions between CD45 and the CD4±TCR complex
(Leitenberg et al., 1996). As T cells differentiate in re- (MHC)±peptide complex plays a positive role by bringing
p56lck into the signaling complex (Weiss and Littman,sponse to antigen receptor signals they expressvariants
of CD45 with fewer amino-terminal exons. An increased 1994). Less well-characterized examples include the
regulation of TCR signaling by interactions between B7association of these isoforms with CD4 appears to occur
and has been suggested to improve the strength or molecules on presenting cells and CD28 or CTLA4 on
T cells, and the inhibition of NK cell cytotoxicity by inter-quality of antigen receptor signaling (Leitenberg et al.,
1996). Another interaction that may take place on the actions between MHC molecules on target cells and
killer inhibitory receptorson NK cells. The possibility thatsurface of B cells and that may be of functional impor-
tance occurs between CD22 and CD45. CD45 binding CD22 and CD45 interact between cells during antigen
presentation by B cells to T cells has been suggestedto CD22 has been well documented, and the strong
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(Stamenkovic et al., 1991; Aruffo etal., 1992). CD22 is not antigen that take place during an immune response and
so amplify or down-regulate the response as appro-expressed by other antigen-presenting cells, however,
indicating either that these cells express other mole- priate.
The observation that a major a2,6-sialylated ligandcules that serve the same purpose, or that the interaction
plays a role that is particular to B cell±T cell interactions. for CD22 present in serum is IgM raises the possibility
that CD22 might also participate in this type of interac-The latter possibility deserves further consideration
since many studies suggest that T cells are poorly acti- tion (Hanasaki et al., 1995). CD22 might act as a form
of IgM FcR, being recruited to the antigen receptor whenvated following an encounter with antigen presented by
B cells; perhaps CD22-mediated cross-linking of CD45 the cell binds IgM±antigen complexes. Suchan interplay
could be especially important in blocking the responseinactivates the positive regulatory function of the phos-
phatase onthe T cell. A general dilemma with implicating of self-reactive B cells that recognize the idiotype of a
secreted IgM molecule (Figure 3C). Measuring the rela-a role for CD22 and CD45 in T cell±B cell interactions
has been the large dimensions of these proteins (van tive affinity of CD22 for different glycoproteins, and es-
tablishing whether the protein backbone of sialylatedder Merwe and Barclay, 1994). The dimensions of CD4
and CD8 are similar to the TCR and MHC and can there- ligands contributes to binding affinity should help to
define which of the many possible CD22 ectodomainfore be accommodated near these complexes at cell±
cell interfaces (van der Merwe and Barclay, 1994). interactions are of physiological importance.
In summary, CD22 plays an important role as a nega-Whether CD45 and CD22 could be accommodated at
such an interface is unknown. tive regulator of antigen receptor signaling in B lym-
phocytes, exemplified by the exaggerated signaling,A possibility that has already been discussed is that
the ectodomains of these large molecules function increased cell death, and reduced response to T-inde-
pendent antigens of CD22-deficient cells. CD22 is alsomore in communicating to the cell its microenvironmen-
tal context rather than participating directly in close cel- important in limiting the size of the B-1 cell compartment
and in controlling production of IgM and IgA. CD22lular associations. Lymphocytes continually recirculate
around the body, moving through nonlymphoid and stands as a striking example of a transmembrane mole-
cule with an extracellular ligand-binding domain of un-lymphoid tissues. A B lymphocyte might encounter anti-
gen outside a lymphoid microenvironment, but it may known function and an intracellular domain that plays
an integral role in controlling the quality or quantity ofbe advantageous to delay full activation of the cell until
it enters an appropriate lymphoid microenvironment. Al- signals from the antigen receptor. As the interactions
between the cytoplasmic domains of CD22 and relatedthough relative expression of a2,6-sialylated carbohy-
drates has not been widely characterized, it has been molecules with intracellular signalingmolecules become
better defined, the major challenge for the future will besuggested that a lower level of such glycans in non-
lymphoid tissues may promote CD22±sIg associations to understand the nature of the extracellular cues that
regulate cytoplasmic domain function, intracellular sig-that dampen signaling, whereas in lymphoid tissue a2,6-
sialylated glycans on other cells may draw CD22 away naling, and cell fate.
from the sIg association and enhance signaling (Figure
Acknowledgments3B; Doody et al., 1995). Within lymphoid tissues, ligands
for CD22 are differentially expressed, being highest
J. G. C. is a Pew scholar and C. C. G. is an investigator of thewithin B cell zones (Sjoberg et al., 1994). Perhaps when
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